ALLO
Price
$2.17
Change
-$0.09 (-3.98%)
Updated
Feb 21 closing price
Capitalization
454.99M
3 days until earnings call
AVBP
Price
$27.07
Change
-$0.32 (-1.17%)
Updated
Feb 21 closing price
Capitalization
912.18M
32 days until earnings call
Ad is loading...

ALLO vs AVBP

Header iconALLO vs AVBP Comparison
Open Charts ALLO vs AVBPBanner chart's image
Allogene Therapeutics
Price$2.17
Change-$0.09 (-3.98%)
Volume$4.88M
Capitalization454.99M
ArriVent BioPharma
Price$27.07
Change-$0.32 (-1.17%)
Volume$238.02K
Capitalization912.18M
ALLO vs AVBP Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. AVBP commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and AVBP is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ALLO: $2.84 vs. AVBP: $26.21)
Brand notoriety: ALLO and AVBP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 1385% vs. AVBP: 78%
Market capitalization -- ALLO: $454.99M vs. AVBP: $912.18M
ALLO [@Biotechnology] is valued at $454.99M. AVBP’s [@Biotechnology] market capitalization is $912.18M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileAVBP’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • AVBP’s FA Score: 0 green, 5 red.
According to our system of comparison, AVBP is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 5 TA indicator(s) are bullish while AVBP’s TA Score has 3 bullish TA indicator(s).

  • ALLO’s TA Score: 5 bullish, 4 bearish.
  • AVBP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than AVBP.

Price Growth

ALLO (@Biotechnology) experienced а +102.86% price change this week, while AVBP (@Biotechnology) price change was -2.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

ALLO is expected to report earnings on Apr 30, 2025.

AVBP is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVBP($912M) has a higher market cap than ALLO($455M). ALLO YTD gains are higher at: 33.333 vs. AVBP (-1.614). AVBP has higher annual earnings (EBITDA): -93.72M vs. ALLO (-256.67M). ALLO has more cash in the bank: 292M vs. AVBP (150M). AVBP has less debt than ALLO: AVBP (317K) vs ALLO (85.1M). ALLO has higher revenues than AVBP: ALLO (43K) vs AVBP (0).
ALLOAVBPALLO / AVBP
Capitalization455M912M50%
EBITDA-256.67M-93.72M274%
Gain YTD33.333-1.614-2,065%
P/E RatioN/AN/A-
Revenue43K0-
Total Cash292M150M195%
Total Debt85.1M317K26,845%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOAVBP
RSI
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
88%
Momentum
ODDS (%)
Bullish Trend 6 days ago
83%
Bearish Trend 6 days ago
90%
MACD
ODDS (%)
Bullish Trend 6 days ago
80%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
77%
Bearish Trend 6 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 6 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 19 days ago
90%
Declines
ODDS (%)
Bearish Trend 13 days ago
87%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
86%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
AVBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with FATE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+39.22%
FATE - ALLO
59%
Loosely correlated
+7.75%
NTLA - ALLO
58%
Loosely correlated
+7.76%
CRSP - ALLO
57%
Loosely correlated
+5.03%
EDIT - ALLO
56%
Loosely correlated
+26.09%
PRME - ALLO
53%
Loosely correlated
+5.28%
More

AVBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVBP has been loosely correlated with ETNB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if AVBP jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVBP
1D Price
Change %
AVBP100%
-1.47%
ETNB - AVBP
34%
Loosely correlated
+3.31%
IPSC - AVBP
34%
Loosely correlated
-0.81%
ALLO - AVBP
34%
Loosely correlated
+39.22%
ADVM - AVBP
33%
Poorly correlated
-7.40%
ABSI - AVBP
32%
Poorly correlated
-0.52%
More